Amiodarone-induced pigmentation resolves after treatment with the Q- switched ruby laser

Archives of Dermatology

Volumn 135, Issue 3, 1999, Pages 251-253

  Karrer, Sigrid ^a   Hohenleutner, Ulrich ^a   Szeimies, Rolf Markus ^a   Landthaler, Michael ^a   Hruza, G J ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ADULT; ARTICLE; CASE REPORT; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEMALE; HEART ARRHYTHMIA; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; PRIORITY JOURNAL; SKIN PIGMENTATION; TREATMENT OUTCOME; YAG LASER;

EID: 0032903920     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.135.3.251     Document Type: Article

References (8)

1. Dootson G, Byatt C. Amiodarone-induced vasculitis and a review of the cutaneous side-effects of amiodarone. Clin Exp Dermatol. 1994;19:422-424.
2. Rappersberger K, Hönigsmann H, Ortel B, Tanew A, Konrad K, Wolff K. Photosensitivity and hyperpigmentation in amiodarone-treated patients: incidence, time course, and recovery. J Invest Dermatol. 1989;93:201-209.
3. Kounis NG, Frangides C, Papadaki PJ, Zavras GM, Goudevenos J. Dosedependent appearance and disappearance of amiodarone-induced skin pigmentation. Clin Cardiol. 1996;19:592-594.
4. Granstein RD, Sober AJ. Drug- and heavy metal-induced hyperpigmentation. J Am Acad Dermatol. 1981;5:1-18.
5. Harris L, McKenna JW, Rowland E, Holt DW, Storey GCA, Krikler DM. Side effects of long-term amiodarone therapy. Circulation. 1983;67:45-51.
6. Michel S, Hohenleutner U, Baümler W, Landthaler M. Q-switched ruby laser in dermatologic therapy: use and indications. Hautarzt. 1997;48:462-470.
7. Knoell KA, Milgraum SS, Kutenplon M. Q-switched ruby laser treatment of minocycline-induced cutaneous hyperpigmentation. Arch Dermatol. 1996;132: 1251-1252.
8. Tsao H, Busam K, Barnhill RL, Dover JS. Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol. 1996;132:1250-1251.